Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer
- PMID: 19204098
- PMCID: PMC2668351
- DOI: 10.1128/JCM.01842-08
Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer
Abstract
In a previous study, we reported that the sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans was 98% when it was applied to 4-mm punch biopsy samples of Buruli lesions. Fine-needle aspiration (FNA) is a less traumatic sampling technique for nonulcerated lesions, and we have studied the sensitivity of PCR using FNA samples. Fine-needle aspirates were taken with a 21-gauge needle from 43 patients diagnosed clinically with M. ulcerans disease. Four-millimeter punch biopsies were obtained for microscopy, culture, and PCR targeting the IS2404 insertion sequence. The sensitivity of PCR using samples obtained by FNA was 86% (95% confidence interval [95% CI], 72 to 94%) compared with that for PCR using punch biopsy samples. In this study, the sensitivities of culture and microscopy for punch biopsy samples were 44% (95% CI, 29 to 60%) and 26% (95% CI, 14 to 41%), respectively. This demonstrates that PCR on an FNA sample is a viable minimally invasive technique to diagnose M. ulcerans lesions.
Similar articles
-
Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an Assay using punch biopsy specimens for diagnosis of Buruli ulcer.J Clin Microbiol. 2005 Aug;43(8):3650-6. doi: 10.1128/JCM.43.8.3650-3656.2005. J Clin Microbiol. 2005. PMID: 16081892 Free PMC article.
-
Fine-needle aspiration, an efficient sampling technique for bacteriological diagnosis of nonulcerative Buruli ulcer.J Clin Microbiol. 2009 Jun;47(6):1700-4. doi: 10.1128/JCM.00197-09. Epub 2009 Apr 22. J Clin Microbiol. 2009. PMID: 19386847 Free PMC article.
-
Use of fine-needle aspiration for diagnosis of Mycobacterium ulcerans infection.J Clin Microbiol. 2010 Jun;48(6):2263-4. doi: 10.1128/JCM.00558-10. Epub 2010 Apr 7. J Clin Microbiol. 2010. PMID: 20375229 Free PMC article.
-
Laboratory diagnosis of Buruli ulcer disease.Future Microbiol. 2010 Mar;5(3):363-70. doi: 10.2217/fmb.10.3. Future Microbiol. 2010. PMID: 20210548 Review.
-
The Buruli Ulcer.Int J Low Extrem Wounds. 2015 Sep;14(3):217-23. doi: 10.1177/1534734615599653. Epub 2015 Aug 18. Int J Low Extrem Wounds. 2015. PMID: 26286931 Review.
Cited by
-
Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics.PLoS Negl Trop Dis. 2010 Nov 2;4(11):e872. doi: 10.1371/journal.pntd.0000872. PLoS Negl Trop Dis. 2010. PMID: 21072233 Free PMC article.
-
IFN-γ and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with Mycobacterium ulcerans infection.PeerJ. 2018 Jul 31;6:e5294. doi: 10.7717/peerj.5294. eCollection 2018. PeerJ. 2018. PMID: 30090691 Free PMC article.
-
Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease.Antimicrob Agents Chemother. 2010 Sep;54(9):3678-85. doi: 10.1128/AAC.00299-10. Epub 2010 Jun 21. Antimicrob Agents Chemother. 2010. PMID: 20566765 Free PMC article. Clinical Trial.
-
Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?Future Microbiol. 2011 Oct;6(10):1185-98. doi: 10.2217/fmb.11.101. Future Microbiol. 2011. PMID: 22004037 Free PMC article. Review.
-
Establishment of quantitative PCR (qPCR) and culture laboratory facilities in a field hospital in benin: 1-year results.J Clin Microbiol. 2014 Dec;52(12):4398-400. doi: 10.1128/JCM.02131-14. Epub 2014 Oct 15. J Clin Microbiol. 2014. PMID: 25320228 Free PMC article.
References
-
- Amofah, G., S. Asamoah, and C. Afram-Gyening. 1998. Effectiveness of excision of pre-ulcerative Buruli lesions in field situations in a rural district in Ghana. Trop. Doct. 2881-83. - PubMed
-
- Asiedu, K., and R. M. Scherpbier (ed.). 2000. Buruli ulcer: Mycobacterium ulcerans infection. WHO/CDS/CPE/GBUI/2000.1. World Health Organization, Geneva, Switzerland.
-
- Buntine, J., and K. E. Crofts. 2001. Buruli ulcer: management of Mycobacterium ulcerans disease. A manual for health care providers. World Health Organization, Geneva, Switzerland. http://www.who.int/gtb-buruli/publications/index.html.
-
- Chauty, A., M. F. Ardant, A. Adeye, H. Euverte, A. Guedenon, C. Johnson, J. Aubry, E. Nuermberger, and J. Grosset. 2007. Promising clinical efficacy of the combination streptomycin-rifampin for the treatment of Buruli ulcer (Mycobacterium ulcerans disease). Antimicrob. Agents Chemother. 514029-4035. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources